Thomas Watkins, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 12,882 shares at $9.90 ($128K) on 2022-06-02, disclosed to the SEC on 2022-06-03.
Seasonal sale ($128k) by Director — this insider has traded VNDA in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.90 | 6,441 | $64K | 50.0% |
| 2 | $9.90 | 6,441 | $64K | 50.0% |
| Total | $9.90 avg | 12,882 | $128K | 100% |
| Filing → |
| HZNP | BUY | 2015-08-21 | $313K | — | Filing → |
| HZNP | BUY | 2015-01-26 | $59K | — | Filing → |
| VNDA | SELL | 2014-03-17 | $618K | — | Filing → |